CVR: 34080534
Secondary names: ABBLO ApS
ABBLO PHARMA ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nic Borch-Christensen and Mie Hjerrild Petersen. The company is owned by ABBLO S.à.r.l. The company has 0 employees. In 2025, the company reported a gross profit of DKK 471,866 and a net result of DKK -152,259 compared with DKK 135,215 the year before. Equity amounted to DKK -238,088.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive handel med medicinalvarer og sygeplejeartikler og anden virksomhed i forbindelse hermed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 472 t. | -152 t. | 1.2 mio. | -238 t. | 1 | |
| 2024 | 855 t. | 135 t. | 1.4 mio. | -86 t. | 1 | |
| 2023 | 806 t. | 107 t. | 1.5 mio. | -221 t. | 1 | |
| 2022 | 1.1 mio. | 301 t. | 1.2 mio. | -328 t. | 1 | |
| 2021 | 740 t. | 285 t. | 882 t. | -629 t. | 1 | |
| 2020 | 376 t. | 214 t. | 764 t. | -914 t. | 1 | |
| 2019 | 306 t. | 100 t. | 516 t. | -1.1 mio. | 1 | |
| 2018 | 146 t. | 12 t. | 576 t. | -1.2 mio. | 1 | |
| 2017 | 120 t. | -84 t. | 560 t. | -1.2 mio. | 1 | |
| 2016 | -217 t. | -380 t. | 388 t. | -1.2 mio. | 1 | |
| 2014 | -126 t. | 2 mio. | 104 t. | -215 t. | - | |
| 2013 | -12 t. | -2.7 mio. | 4.2 mio. | -2.2 mio. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
ABBLO PHARMA ApS has published its annual report for 2025. Gross profit came to DKK 471,866, and the net result was DKK -152,259.
ABBLO PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 854,994, and the net result was DKK 135,215.
ABBLO PHARMA ApS has published its annual report for 2023. Gross profit came to DKK 806,142, and the net result was DKK 107,380.
ABBLO PHARMA ApS has published its annual report for 2022. Gross profit came to DKK 1,056,147, and the net result was DKK 300,769.
ABBLO PHARMA ApS has published its annual report for 2021. Gross profit came to DKK 740,462, and the net result was DKK 285,238.
ABBLO PHARMA ApS has published its annual report for 2020. Gross profit came to DKK 375,630, and the net result was DKK 213,834.
ABBLO PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 306,373, and the net result was DKK 100,475.
ABBLO PHARMA ApS has published its annual report for 2018. Gross profit came to DKK 145,533, and the net result was DKK 12,115.
ABBLO PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 119,645, and the net result was DKK -84,087.
ABBLO PHARMA ApS has published its annual report for 2016. Gross profit came to DKK -216,678, and the net result was DKK -379,981.
ABBLO PHARMA ApS has published its interim report for the period October 1, 2014 – December 31, 2015.
As of January 1, 2016, Nic Borch-Christensen has joined the board of directors of ABBLO PHARMA ApS.
As of January 1, 2016, Mie Hjerrild Petersen has joined the board of directors of ABBLO PHARMA ApS.
As of January 1, 2016, Nic Borch-Christensen is registered as adm. dir. of ABBLO PHARMA ApS.
As of January 1, 2016, Mie Hjerrild Petersen is registered as suppleant of ABBLO PHARMA ApS.
As of December 31, 2015, Mie Hjerrild Petersen has stepped down as adm. dir. of ABBLO PHARMA ApS.
As of January 15, 2015, Mie Hjerrild Petersen is registered as adm. dir. of ABBLO PHARMA ApS.
As of January 15, 2015, Nic Borch-Christensen has stepped down as director of ABBLO PHARMA ApS.
ABBLO PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -125,983, and the net result was DKK 2,000,538.
As of November 27, 2014, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ABBLO PHARMA ApS.
As of October 7, 2014, Beierholm Godkendt Revisionspartnerselskab has been appointed auditor of ABBLO PHARMA ApS.
As of October 7, 2014, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ABBLO PHARMA ApS.
As of October 1, 2014, is registered as an owner of ABBLO PHARMA ApS with an ownership share of 100%.
ABBLO PHARMA ApS has published its annual report for 2013. Gross profit came to DKK -11,750, and the net result was DKK -2,697,303.
ABBLO PHARMA ApS has published its interim report for the period December 13, 2011 – September 30, 2012.
As of December 13, 2011, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ABBLO PHARMA ApS.
As of December 13, 2011, Nic Borch-Christensen is registered as director of ABBLO PHARMA ApS.
ABBLO PHARMA ApS was founded on December 13, 2011.
Companies in the same industry and area
CVR 44510014
CVR 46122992
CVR 27299032
CVR 46607503
CVR 44646021
companydata.dk